Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea

Silke Ryan (Dublin, Ireland)

Source: International Congress 2015 – Obstructive sleep apnoea in adults and children
Session: Obstructive sleep apnoea in adults and children
Session type: Session
Number: 441
Disease area: Sleep and breathing disorders

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Silke Ryan (Dublin, Ireland). Cournand lecture - Inflammatory pathway activation by intermittent hypoxia in obstructive sleep apnoea. International Congress 2015 – Obstructive sleep apnoea in adults and children

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Intermittent hypoxia in sleep apnea: a cause of inflammatory activation
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007


Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation
Source: Eur Respir J 2009; 33: 1195-1205
Year: 2009



Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016


Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013


Hypoxic stress in obstructive sleep apnea syndrome (OSAS) activates invasive ability of monocytes
Source: Eur Respir J 2005; 26: Suppl. 49, 354s
Year: 2005

Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


A simple device to subject cells to intermittent hypoxia mimicking obstructive sleep apnea
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Ventilatory response amongst patients with obstructive sleep apnoea
Source: International Congress 2016 – Central sleep apnoea and the central regulation of obstructive and central sleep apneoa
Year: 2016


Selective activation of pro-inflammatory cytokines in obstructive sleep apnoea syndrome and impact of CPAP
Source: Eur Respir J 2005; 26: Suppl. 49, 355s
Year: 2005

Is snoring the cause of oxidative stress in airways in obstructive sleep apnea patients?
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005


Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia
Source: Eur Respir J 2012; 39: 1492-1500
Year: 2012



Mechanisms and assessment of vascular damage in obstructive sleep apnoea
Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea”
Year: 2013


5-lipoxygenase pathway: one of the mediators of early atherosclerosis in obstructive sleep apnea syndrome?
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007


Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives
Source: Eur Respir J 2008; 32: 1082-1095
Year: 2008



Pathophysiology of the upper airway in obstructive sleep apnoea
Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts
Year: 2006



NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015

Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

The role of inflammatory biomarkers in obstructive sleep apnea syndrome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018